Quarterly report [Sections 13 or 15(d)]

Consolidated Condensed Balance Sheets

v3.26.1
Consolidated Condensed Balance Sheets - USD ($)
shares in Millions, $ in Millions
Mar. 28, 2026
Dec. 27, 2025
Current assets:    
Cash and cash equivalents $ 17,247 $ 14,265
Short-term investments 15,542 23,151
Accounts receivable, net 4,066 3,839
Inventories 12,426 11,618
Other current assets 12,876 10,815
Total current assets 62,157 63,688
Property, plant, and equipment, net of accumulated depreciation of $107,896 ($106,464 as of December 27, 2025) 104,458 105,414
Equity Investments 8,481 8,512
Goodwill 20,465 23,912
Identified intangible assets, net 2,722 2,772
Other long-term assets 7,049 7,131
Total assets 205,332 211,429
Current liabilities:    
Short-term debt 2,004 2,499
Accounts payable 7,159 9,882
Accrued compensation and benefits 2,824 3,990
Other accrued liabilities 14,898 15,204
Total current liabilities 26,885 31,575
Debt 43,027 44,086
Other long-term liabilities 10,431 9,408
Contingencies (Note 14)
Stockholders’ equity:    
Common stock and capital in excess of par value, 5,023 issued and outstanding (4,994 issued and outstanding as of December 27, 2025) 66,259 65,185
Accumulated other comprehensive income (loss) (44) 113
Retained earnings 45,179 48,983
Total stockholders' equity 111,394 114,281
Non-controlling interest 13,595 12,079
Accumulated other comprehensive income (loss) 124,989 126,360
Total liabilities and stockholders’ equity $ 205,332 $ 211,429
Common Stock, Shares, Outstanding 5,023 4,994